Current Trends in Hemoadsorption Therapy in the Field of Heart Failure and ECMO Therapy

Dear Colleagues,

This Special Issue of Reviews in Cardiovascular Medicine focuses on current trends in hemoadsorption therapy in the field of heart failure.

It is a great pleasure for our team to act as guest editors for this Special Issue of Reviews in Cardiovascular Medicine. The incidence of heart failure is projected to increase by almost 50% by 2030 in all western countries due to their aging population. New concepts, platforms and devices for mechanical circulatory support (MCS) will continue to be further developed in the near future due to the relative scarcity of transplant organs. Consequently, the use of MCS has grown significantly, particularly as a bridge to transplantation.

Extracorporeal blood purification techniques have recently gained attention in various fields of clinical medicine and especially in heart failure patients, for VAD implantation, during heart transplantation, as well as during ex-vivo perfusion in order to improve donor organ function. In the setting of “donation after circulatory death”, ex-vivo perfusion combined with hemoadsorption holds particular promise for the preservation of organ function and thus leading to a higher percentage of transplantable organs.

Hemoadsorption has the ability to modulate the immune response not only by attenuating pro-inflammatory cytokines, but also by lowering the levels of myoglobin, creatine kinase, lactate and many other mediators. Moreover, in the clinical setting it is used postoperatively to decrease inotropic support.

The aim of this Special Issue is therefore to provide readers with an update of the current use of hemoadsorption technologies in the growing field of heart failure therapy.

Prof. Dr. Nandor Marczin, Prof. Dr. Aaron Popov, Prof. Dr. Eric de Waal, Prof. Dr. Daniel Wendt and Prof. Dr. Alexander Weymann

Guest Editors

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.